The 20 Best Hyphema Doctors near Ventura, CA

Jeffrey Luttrull is an Ophthalmologist in Ventura, California. Dr. Luttrull is rated as an Advanced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy. Dr. Luttrull is currently accepting new patients.

Steven Chang is an Ophthalmologist in Ventura, California. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Cataract, Entropion, Dry Eye Syndrome, and Glaucoma. Dr. Chang is currently accepting new patients.

Bryant Lum is an Ophthalmologist in Ventura, California. Dr. Lum is rated as an Advanced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Glaucoma, Dry Eye Syndrome, Ocular Hypertension (OHT), and Optic Atrophy Type 1.

Dr. Dante J. Pieramici graduated with honors from the Johns Hopkins University School of Medicine and completed Ophthalmology Residency at the Wilmer Eye Institute. He receive vitreoretinal fellowship training at the Emory Eye Center in Atlanta Georgia. Dr. Pieramici has held full-time academic positions at the Yale University Eye Center and the Wilmer Eye Institute, where he served as the Assistant Chief of Service and Director of Ocular Trauma. Currently he is the Codirector of the California Retina Research Foundation, a partner of the California Retina Consultants, and Assistant Clinical Professor of Ophthalmology at the Doheny Eye Center in Southern California. Dr. Pieramici has published over 100 articles, 16 book chapters, and has edited 3 books on retinal diseases. He lectures nationally and internationally on retinal diseases and ocular trauma.Dr. Pieramici’s research interests have been varied, and include clinical and basic science projects aimed at better understanding of the underlying pathophysiology of ocular diseases, so as to improve treatments for patients with age-related macular degeneration, diabetic retinopathy, retinal vascular diseases, and severe ocular injuries. He has been a clinical investigator, principal investigator, or reading center investigator in numerous NIH and pharmaceutical company sponsored clinical trials. Dr Pieramici has helped in the development of new surgical techniques including limited macular translocation and 25-gauge (small incision) vitrectomy surgery. Currently he is involved in the development of new drug delivery techniques for various retinal vascular diseases.Dr. Pieramici has received the Achievement Award from the American Academy of Ophthalmology and Honor Award from the American Society of Retinal Specialists. He is a member of the American Academy of Ophthalmology, the Retina Society, the Macula Society, the American Society of Retinal Specialists, the Association for Research in Vision and Ophthalmology, the American Society of Ocular Trauma where he serves as Vice President, and the Pan-American Ophthalmologic Society amongst others. Dr Pieramici is a member of S.E.E International and regularly trains international ophthalmologists from undeserved areas.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients. Dr. Pieramici is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Diabetic Retinopathy, and Vitrectomy.

Dr. Castellarin graduated first in his class from the University of Verona School of Medicine in Verona, Italy. Following his ophthalmology training, he completed an ophthalmology residency summa cum laude and then became an instructor of ophthalmology at the Verona School of Medicine. In addition to working in a clinical practice, Dr. Castellarin was a primary investigator in the Verona Diabetes Study.After several years of research and teaching in Italy, Dr. Castellarin moved to the United States where he completed a general surgery internship at St. Barnabas Medical Center. Then, during an additional ophthalmology residency at the University of Medicine and Dentistry in Newark , New Jersey, Dr. Castellarin was chosen to be chief resident. He was also presented with the Alfonse Cinotti Award in recognition of his academic and professional excellence as an ophthalmology resident. Dr. Castellarin received his vitreoretinal fellowship training at Emory University with pioneer surgeon, Dr. Thomas Aaberg.Dr. Castellarin has recently been nationally recognized as the top retina fellow. He was presented with the prestigious Ronald M. Michels Fellowship Award for his contributions to vitreoretinal research and surgery. He was also honored with a National Eye Institute Travel Grant during his work at Emory University. His research interests include diabetic retinopathy, age-related macular degeneration and retinal pigment epithelium transplantation. Dr. Castellarin has also been involved in several national multicenter clinical trials and results of his work have been published in highly acclaimed journals such as Ophthalmology, Retina, the American Journal of Ophthalmology, the British Journal of Ophthalmology and The Lancet. Dr. Castellarin is a diplomate of the American Board of Ophthalmology, a member of the Association for Research in Vision and Ophthalmology and the American Academy of Ophthalmology.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients. Dr. Castellarin is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Retinal Vein Occlusion, and Vitrectomy.

Anya Trumler is a Pediatrics provider in Ventura, California. Dr. Trumler is rated as an Experienced provider by MediFind in the treatment of Hyphema. Her top areas of expertise are Strabismus, Esotropia, Astigmatism, and Amblyopia.

Scott Speier is a primary care provider, practicing in Family Medicine in Ventura, California. Dr. Speier is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Morning Sickness, Trichohepatoenteric Syndrome, Diarrhea, and Headache.

Richard Rutherford is a primary care provider, practicing in Family Medicine in Ventura, California. Dr. Rutherford is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Morning Sickness, Alcoholic Ketoacidosis, Vertigo, and Trichohepatoenteric Syndrome.

Erin Bergeron is a primary care provider, practicing in Family Medicine in Oxnard, California. Dr. Bergeron is rated as an Experienced provider by MediFind in the treatment of Hyphema. Her top areas of expertise are Food Allergy, Obesity in Children, Chronic Obstructive Pulmonary Disease (COPD), and Lung Metastases.

Alexander Castro is an Ophthalmologist in Camarillo, California. Dr. Castro has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Hyphema. His top areas of expertise are Amblyopia, Strabismus, Oculomotor Apraxia Cogan Type, and Esotropia. Dr. Castro is currently accepting new patients.